Basmah Alharbi | Microbiology | Best Researcher Award

Dr. Basmah Alharbi | Microbiology | Best Researcher Award

Assistant Professor of Epidemiology from Qassim University, Saudi Arabia

Dr. Basmah Fehaid Al-Wahbi Al-Harbi is a dedicated academic and researcher currently serving as an Assistant Professor at the College of Applied Medical Sciences, Qassim University, Kingdom of Saudi Arabia. Her career reflects a balanced integration of clinical expertise, public health research, and educational leadership. With a strong background in epidemiology and public health, she has contributed to significant scholarly work addressing issues such as infectious diseases, physical activity among Saudi women, and evidence-based healthcare practices. Her administrative roles, including Vice Dean of Female Students Affairs and Chair of various academic committees, reflect her leadership within the academic community. Dr. Alharbi’s international education and research experiences in Australia and the United Kingdom have given her a broad global perspective. Her work has been recognized through numerous prestigious awards, and she has actively participated in international conferences and peer-review processes. As an infection control consultant and researcher, she also plays a vital role in bridging clinical application with scientific evidence. Overall, Dr. Alharbi stands out as a proactive and impactful researcher whose academic journey and contributions significantly enrich the field of public health and applied medical sciences.

Professional Profile

Education

Dr. Basmah Fehaid Al-Wahbi Al-Harbi holds an impressive academic record with degrees from prestigious institutions across three countries. She earned her Ph.D. in Epidemiology from the Public Health and Social Work College at Queensland University of Technology, Brisbane, Australia, in 2022, graduating with outstanding distinction. Her doctoral work focused on understanding young Saudi women’s beliefs regarding physical activity, utilizing mixed-method approaches. Prior to this, she completed her Master of Science in Health Promotion and Public Health with distinction and honors from Ulster University, Northern Ireland, United Kingdom, in 2016. Her foundational academic background includes a Bachelor of Science degree in Medical Laboratories from Al-Qassim University, Saudi Arabia, completed in 2013 with an excellent rating and second-class honors. In addition to her academic degrees, she has obtained professional certifications including a Training of Trainers (TOT) certificate from the Technical and Vocational Training Corporation in 2022 and an International Certificate in IT Skills approved by the Ministry of Education in 2014. This combination of academic and professional qualifications highlights her solid grounding in both research and practical applications within public health and laboratory sciences.

Professional Experience

Dr. Alharbi’s professional career reflects a progressive and diverse trajectory in academia, research, clinical settings, and administration. She currently serves as an Assistant Professor in the Basic Health Science Department at the College of Applied Medical Sciences, Qassim University, a role she has held since 2022. In parallel, she also functions as an Infection Control Consultant at Qassim University Medical City. Her previous academic roles include Lecturer and Teaching Assistant within the same college, highlighting her long-term commitment to the university and student development. Her clinical experience began with an internship as a Medical Laboratory Specialist at King Fahad Specialist Hospital and the Maternity and Children Hospital of Buraidah between 2012 and 2013. Dr. Alharbi also holds key administrative responsibilities, having served as Vice Dean of the Female Campus and Vice Dean of Female Students Affairs at Qassim University. She has chaired disciplinary and guidance committees, and she is currently a member of the Permanent Extraordinary Increases Committee. Her experience in teaching, clinical work, and university governance demonstrates her capability to lead multifaceted roles within academic institutions, strengthening her influence in both education and healthcare systems.

Research Interest

Dr. Alharbi’s research interests are rooted in public health, epidemiology, and behavioral health promotion, with a specific focus on women’s health, infectious disease control, and health behavior interventions. Her academic work frequently explores sociocultural dimensions of health, particularly in the context of Saudi Arabia. She has conducted qualitative and quantitative studies on topics such as physical activity among Saudi women, student engagement in evidence-based healthcare practices, and preventive measures for traveler’s diarrhea. Her interest in epidemiological mapping is evident in her work on cutaneous leishmaniasis, which aligns with regional healthcare concerns. She has also contributed to international health research by co-authoring studies on COVID-19 and hemorrhagic fever with renal syndrome (HFRS) using machine learning and gene expression data analysis. Her interdisciplinary focus combines biomedical sciences, behavioral theories, and data-driven health assessments. With a strong interest in global and regional health challenges, Dr. Alharbi continues to expand her research to address public health gaps, promote evidence-based policy recommendations, and improve population health outcomes through both clinical and community-focused strategies.

Research Skills

Dr. Alharbi possesses a comprehensive and diverse set of research skills that span the domains of epidemiology, public health, and clinical laboratory sciences. She is proficient in designing and conducting both qualitative and quantitative studies, as demonstrated by her mixed-method doctoral research on physical activity behaviors. Her ability to perform psychometric evaluations is evidenced by her work on validating Arabic versions of evidence-based practice scales for undergraduate nursing students. Dr. Alharbi is skilled in conducting systematic reviews and meta-analyses, as shown by her publication on probiotics and traveler’s diarrhea. She demonstrates expertise in biostatistics, data interpretation, public health surveys, and infectious disease surveillance. Moreover, she integrates innovative approaches like machine learning into epidemiological research, highlighting her adaptability to emerging scientific methodologies. Her peer-review activities for international conferences also show her ability to critically assess academic work. Her background as a medical laboratory specialist further supports her skills in microbiological analysis and infection control. Overall, her robust technical and analytical abilities, combined with her interdisciplinary approach, make her a well-rounded and capable researcher capable of leading impactful studies in public and global health.

Awards and Honors

Dr. Alharbi has received multiple awards and honors that recognize her academic excellence, research achievements, and leadership contributions. She was awarded the Outstanding Doctoral Thesis Award in 2023 by Queensland University of Technology, Australia, for her exceptional research on Saudi women’s physical activity beliefs. In 2021, she received the Young Investigator Award at the 52nd Asia Pacific Academic Consortium for Public Health Conference in Indonesia, underlining her international recognition. Her contributions have also been celebrated within the Kingdom of Saudi Arabia, where she earned the 1st Best Presenter and Best Poster Presentation Awards at the 3rd Regional Public Health Conference in Riyadh in 2019. Dr. Alharbi was honored with the Distinction Prize for Scientific Excellence by the Saudi Arabian Cultural Bureaus in both Canberra, Australia (2020), and London, UK (2016), highlighting her consistent academic performance abroad. Additionally, she ranked third among high school students in Jeddah in 2005, marking the beginning of her academic excellence from an early age. These accolades affirm her dedication to scientific research and public health advocacy and serve as strong endorsements of her contributions to both local and global health scholarship.

Conclusion

In conclusion, Dr. Basmah Fehaid Al-Wahbi Al-Harbi exemplifies the qualities of a distinguished researcher, educator, and healthcare advocate. Her multidisciplinary academic background, paired with a steady trajectory of professional growth in academia and public health, positions her as a leading figure in the field. Her research demonstrates both depth and breadth, addressing regional health issues with global relevance, and she effectively bridges the gap between theory and practice. Dr. Alharbi’s ability to integrate epidemiological methods with behavioral science frameworks makes her contributions particularly impactful in the promotion of health education and preventive care strategies. Her numerous national and international awards speak to her credibility and dedication, while her leadership roles within Qassim University underline her institutional commitment. While there is potential for further development through expanded international collaborations and externally funded research projects, her current achievements are substantial and commendable. Dr. Alharbi’s profile reflects a researcher who not only contributes to scientific knowledge but also influences policy, education, and clinical practice. She is undoubtedly a strong and deserving candidate for the Best Researcher Award.

Publications Top Notes

  1. Title: A Psychometric Study of the Student Evidence-Based Practice Scale S-EBPQ-Arabic Version for Use among Undergraduate Nursing Students
    Journal: International Journal of Clinical Practice
    Year: 2024
    Author(s): Alharbi, B.F.

  2. Title: Bioinformatics and immunoinformatics assisted multiepitope vaccine construct against Burkholderia anthina
    Journal: Saudi Pharmaceutical Journal
    Year: 2024
    Author(s): Alshiekheid, M.A.; Dou, A.M.; Algahtani, M.; Al-Megrin, W.A.I.; Alhawday, Y.A.; Alradhi, A.E.; Bukhari, K.; Alharbi, B.F.; Algefary, A.N.; Alhunayhani, B.A. et al.

  3. Title: Evaluation of the immune system status and hematological dyscrasias, among amphetamine and cannabis abusers at Eradah Hospital in Qassim, Saudi Arabia
    Journal: Scientific Reports
    Year: 2024
    Author(s): Mohammed, A.H.; Aljarallah, A.S.; Huq, M.; Mackawy, A.M.H.; Alharbi, B.F.; Almutairi, K.S.; Alruwetei, A.M.; Almatroudi, A.A.A.; Alharbi, H.O.; Aljohery, S.A.M.A. et al.

  4. Title: Investigating the beliefs of Saudi females regarding physical activity: a qualitative exploration
    Journal: International Journal of Qualitative Studies on Health and Well-being
    Year: 2024
    Author(s): Alharbi, B.F.H.; Baker, P.; Pavey, T.; Alharbi, M.F.

  5. Title: Investigating the influence of probiotics in preventing Traveler’s diarrhea: Meta-analysis based systematic review
    Journal: Travel Medicine and Infectious Disease
    Year: 2024
    Author(s): Alharbi, B.F.; Alateek, A.A.

  6. Title: Patients’ Response to Treatment for Amphetamine and Cannabis Abuse in Eradah and Mental Health Hospital in Al-Qassim Region, Saudi Arabia
    Journal: Migration Letters
    Year: 2023
    Author(s): Basmah Fehaid Alharbi

  7. Title: Physical Exercise Impact on Hormonal Homeostasis Among Group of Women
    Journal: Migration Letters
    Year: 2023
    Author(s): Basmah Fehaid Alharbi

  8. Title: Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways
    Journal: International Journal of Molecular Sciences
    Year: 2023
    Author(s): Arshad Rahmani; Ahmad Almatroudi; Khaled Allemailem; Wanian Alwanian; Basmah Alharbi; Faris Alrumaihi; Amjad Ali Khan; Saleh A. Almatroodi

  9. Title: Effects and Mechanisms of Kaempferol in the Management of Cancers through Modulation of Inflammation and Signal Transduction Pathways
    Journal: International Journal of Molecular Sciences
    Year: 2023
    Author(s): Ahmad Almatroudi; Khaled Allemailem; Wanian M. Alwanian; Basmah F. Alharbi; Faris Alrumaihi; Amjad Ali Khan; Saleh A. Almatroodi; Arshad Husain Rahmani

Mitra Tavakoli | Green Chemistry | Global Health Impact Award

Assoc. Prof. Dr. Mitra Tavakoli | Green Chemistry | Global Health Impact Award

Associate Professor in Chemical and polymer Engineering Department from Yazd University, Iran

Dr. Mitra Tavakoli Ardakani is an Associate Professor in the Chemical and Polymer Engineering Group at Yazd University, Iran. With a career spanning over two decades, she has made significant contributions to the field of polymer engineering, particularly in the development and characterization of polymer nanocomposites. Her research encompasses areas such as rubber blends, polymer processing, tissue engineering, and hydrogels. Dr. Tavakoli has published extensively in reputable journals and has presented her work at numerous national and international conferences. Her academic endeavors are complemented by her commitment to teaching and mentoring, having supervised several master’s theses. Through her research and academic activities, Dr. Tavakoli continues to advance the field of polymer science, contributing to both academic knowledge and practical applications.

Professional Profile

Education

Dr. Tavakoli’s academic journey in polymer engineering began with a Bachelor of Science degree from Amirkabir University, followed by a Master of Science and a Ph.D. in the same field from the same institution. Her doctoral research focused on the development of polymer nanocomposites, laying the groundwork for her future research endeavors. This strong educational foundation has equipped her with the theoretical knowledge and practical skills necessary to excel in her field.

Professional Experience

Throughout her tenure at Yazd University, Dr. Tavakoli has held various administrative and academic positions. She served as the Deputy in the Yazd Standard Office from 2015 to 2020, where she was involved in setting and maintaining academic standards. Between 2012 and 2014, she was the Director of Educational Affairs, overseeing curriculum development and academic policies. Earlier, from 2002 to 2005, she managed the university’s publishing department. In addition to these roles, Dr. Tavakoli has been actively involved in teaching, offering courses such as Chemistry and Polymerization Kinetics, Energy and Mass Balance, and Advanced Physical Chemistry of Polymers.

Research Interests

Dr. Tavakoli’s research interests are diverse and interdisciplinary, focusing on the synthesis and characterization of polymer nanocomposites, rubber blends, and the irradiation of polymers. She is particularly interested in the application of these materials in tissue engineering and food packaging. Her work on hydrogels and aerogels explores their potential in biomedical applications, while her studies on polymer processing aim to enhance material properties for industrial use. By integrating principles from chemistry, materials science, and engineering, Dr. Tavakoli seeks to develop innovative solutions to contemporary challenges in health and sustainability.

Research Skills

Dr. Tavakoli possesses a comprehensive skill set in polymer science, including expertise in polymer synthesis, characterization techniques, and material testing. She is proficient in various analytical methods such as spectroscopy, rheology, and microscopy, which she employs to investigate the structural and mechanical properties of polymeric materials. Her experience with irradiation techniques, including electron beam processing, allows her to modify polymer structures for specific applications. Additionally, her proficiency in experimental design and statistical analysis enables her to optimize material properties effectively.

Awards and Honors

Dr. Tavakoli’s contributions to polymer engineering have been recognized through her involvement in scientific committees and editorial boards. She has served as a member of the scientific committee and jury for the 7th National Polymer Conference of Iran in 2023. Her research has been published in high-impact journals, reflecting the significance and quality of her work. Through her academic and professional achievements, Dr. Tavakoli has established herself as a respected figure in the field of polymer science.

Conclusion

Dr. Mitra Tavakoli Ardakani’s extensive experience in polymer engineering, combined with her dedication to research and education, positions her as a valuable contributor to advancements in material science. Her work on polymer nanocomposites and their applications in health and environmental sectors demonstrates her commitment to addressing global challenges. By fostering interdisciplinary collaborations and mentoring the next generation of scientists, Dr. Tavakoli continues to influence the field positively. Her achievements reflect a career dedicated to scientific excellence and societal impact.

Publications Top Notes

  • Title: NR/SBR/organoclay nanocomposites: Effects of molecular interactions upon the clay microstructure and mechano‐dynamic properties
    Authors: M. Tavakoli, A.A. Katbab, H. Nazockdast
    Year: 2012
    Citations: 37

  • Title: Effectiveness of maleic anhydride grafted EPDM rubber (EPDM-g-MAH) as compatibilizer in NR/organoclay nanocomposites prepared by melt compounding
    Authors: M. Tavakoli, A.A. Katbab, H. Nazockdast
    Year: 2011
    Citations: 35

  • Title: Surface modification of polymers to enhance biocompatibility
    Authors: M. Tavakoli
    Year: 2005
    Citations: 27

  • Title: Mechanical and thermal properties of octadecylamine-functionalized graphene oxide reinforced epoxy nanocomposites
    Authors: S. Jahandideh, M.J.S. Shirazi, M. Tavakoli
    Year: 2017
    Citations: 22

  • Title: Styrene butadiene rubber/epoxidized natural rubber (SBR/ENR50) nanocomposites containing nanoclay and carbon black as fillers for application in tire-tread compounds
    Authors: S. Ahmadi Shooli, M. Tavakoli
    Year: 2016
    Citations: 22

  • Title: Styrene butadiene rubber/epoxidized natural rubber/carbon filler nanocomposites: microstructural development and cure characterization
    Authors: S. Khalifeh, M. Tavakoli
    Year: 2019
    Citations: 12

  • Title: A Comparative Study of the Dynamic-Mechanical Properties of Styrene Butadiene Rubber/Epoxidized Natural Rubber Dual Filler Nanocomposites Cured by Sulfur or Electron Beam
    Authors: S.A.S.M. Tavakoli
    Year: 2019
    Citations: 11

  • Title: Enhancement in the mechanical property of NBR/PVC nanocomposite by using sulfur and electron beam curing in the presence of Cloisite 30B nanoclay
    Authors: A.S. Rad, E. Aali, S. Hallajian, D. Zangeneh, M. Tavakoli, K. Ayub, M. Peyravi
    Year: 2020
    Citations: 8

  • Title: Coincident optimization of specific volume and tensile strength at acrylic high-bulked yarn using Taguchi method
    Authors: M. Sadeghi-Sadeghabad, M. Tavakoli, A. Alamdar-Yazdia, H. Mashroteha
    Year: 2015
    Citations: 8

Jindian Duan | Organic Chemistry | Best Researcher Award

Prof. Jindian Duan | Organic Chemistry | Best Researcher Award

Associate Professor from Nanjing Tech University, China

Jindian Duan, born in 1985 in Luoyang, Henan Province, is an accomplished associate professor and Master’s supervisor at the College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University. His research focuses on developing novel processes and materials using microfluidic technology and bio-based chemicals. He has made significant contributions to the scientific community with over 20 publications in high-impact international journals, including Org. Lett., Chem. Commun., and Adv. Synth. Catal. His research achievements have earned him more than 10 Chinese invention patents. Duan’s career reflects both academic excellence and an ongoing commitment to advancing cutting-edge technologies in organic chemistry. With a strong educational background and extensive professional experience, he continues to make valuable contributions to the fields of chemistry and biotechnology.

Professional Profile

Education

Jindian Duan’s educational background includes a Ph.D. in Organic Chemistry from Zhejiang University, completed in 2013. His doctoral research, under the supervision of Prof. Cheng Ma, focused on asymmetric catalytic cascade reactions. Before this, he earned a Master of Engineering in Chemical Engineering from Zhejiang University in 2008, where he worked on the intermediate of the fungicide fludioxonil under the guidance of Prof. Lirong Yang. His academic journey began at Dalian University of Technology, where he obtained a B.Sc. in Chemistry in 2006. These advanced degrees laid the foundation for his current expertise in organic chemistry and chemical engineering, enabling him to contribute significantly to his field.

Professional Experience

Jindian Duan’s professional career spans several prestigious academic institutions. Since May 2017, he has served as an associate professor at Nanjing Tech University, where he also supervises Master’s students. Prior to this, Duan was a postdoctoral researcher at The Hong Kong Polytechnic University from 2015 to 2017, specializing in transition metal-catalyzed coupling reactions. He also worked as an assistant researcher at the Southern University of Science and Technology from 2013 to 2015, where he focused on asymmetric catalytic cascade reactions of organic small molecules. Earlier in his career, Duan worked as a technology transfer engineer and chemical process engineer at Lonza R&D Center in Guangzhou, where he was involved in the scale-up and pilot production of pharmaceutical intermediates.

Research Interests

Jindian Duan’s primary research interests lie in the development of novel processes and materials based on microfluidic technology. His work is focused on advancing bio-based chemicals and creating innovative approaches to organic chemistry. Duan’s research has led to the development of new catalytic processes and materials, with particular emphasis on environmentally friendly and sustainable practices. He is also engaged in the development of transition metal-catalyzed reactions and asymmetric catalytic cascade reactions. His research is highly interdisciplinary, bridging the fields of microfluidics, green chemistry, and biotechnology.

Research Skills

Duan’s research skills are rooted in his deep understanding of organic chemistry and chemical engineering. He is proficient in microfluidic technology and its application to the synthesis of novel materials and bio-based chemicals. His work in asymmetric catalytic reactions has been groundbreaking, and his expertise extends to the development of scalable, sustainable chemical processes. Duan is skilled in various advanced techniques such as transition metal-catalyzed reactions, synthetic organic chemistry, and the design of catalytic systems. He is also experienced in patenting innovative solutions, having filed over 10 Chinese invention patents. His collaborative work in multidisciplinary teams further enhances his research capabilities.

Awards and Honors

Jindian Duan’s research excellence has been recognized through numerous accolades and awards. He has published over 20 high-impact papers in prestigious journals, marking him as a leading figure in his field. Additionally, his contributions to innovative chemical processes and materials have earned him more than 10 Chinese invention patents. Duan’s work on bio-based chemicals and microfluidic technology has not only enriched the scientific community but also contributed to the development of sustainable practices in chemistry. His ongoing commitment to research and innovation continues to be acknowledged by both academic and industrial sectors.

Conclusion

Jindian Duan is a highly accomplished researcher whose work in microfluidic technology and bio-based chemicals has significantly advanced the fields of organic chemistry and biotechnology. His impressive publication record and over 10 granted patents reflect his ability to push the boundaries of scientific research. As an associate professor and supervisor at Nanjing Tech University, Duan also plays a key role in shaping the next generation of researchers. His combination of innovative research, strong academic leadership, and commitment to sustainability makes him a valuable asset to the scientific community. Looking forward, Duan’s continued contributions are expected to have a lasting impact on the fields he specializes in.

Publications Top Notes

Electrochemical Reductive Bimolecular Cycloaddition of 2-Arylideneindane-1,3-diones for the Synthesis of Spirocyclopentanole Indane-1,3-diones
Authors: Luchao Li, Binyan Xu, Chenglong Jia, Jindian Duan, Kai Guo
Journal: Journal of Organic Chemistry
Year: 2025

2. Oxidative Spirolactonisation for Modular Access of γ-Spirolactones via a Radical Tandem Annulation Pathway
Authors: Jindian Duan, Xiaojuan Ding, Pui Ying Choy, Fuk Yee Kwong, Kai Guo
Journal: Chinese Chemical Letters
Year: 2024
Citations: 1

3. Copper(I)-Catalyzed [4+2] Oxidative Annulation of α,β-Unsaturated Ketoxime Acetates with Cyclopropanols toward Functional Pyridines
Authors: Qinghuan Wu, Gaochen Xu, Yuguang Li, Jindian Duan, Kai Guo
Journal: Advanced Synthesis and Catalysis
Year: 2023
Citations: 1

Zhishuai Geng | Chemistry | Best Researcher Award

Prof. Zhishuai Geng | Chemistry | Best Researcher Award

Assistant Professor from Beijing Institute of Technology, China

Zhishuai Geng is a highly accomplished researcher and Assistant Professor at the School of Materials Science and Engineering, Beijing Institute of Technology. With a strong academic background and a distinguished postdoctoral tenure at the University of California, Santa Barbara, Dr. Geng has positioned himself at the forefront of polymer materials research. His work encompasses dynamic polymer networks, self-healing materials, recyclable polymers, and flame-retardant systems, all aimed at creating sustainable, multifunctional, and high-performance materials. He has authored and co-authored numerous publications in top-tier journals such as ACS Applied Materials & Interfaces, Macromolecules, Chemical Engineering Journal, and Journal of Polymer Science. In addition to his academic contributions, Dr. Geng is also an inventor with several patents in the areas of antibacterial polyurethanes and functional polymeric materials. His engagement with the scientific community is evident through his active peer-review duties for prominent journals and participation in major scientific conferences. Dr. Geng’s innovative work reflects a balance between fundamental chemistry and real-world applications, earning him recognition as an emerging leader in the field. His commitment to solving complex challenges in materials science through interdisciplinary strategies makes him an excellent candidate for prestigious research awards and future academic leadership roles.

Professional Profile

Education

Zhishuai Geng’s academic journey began with a Bachelor of Science in Materials Chemistry from Nankai University, China, completed in 2012. This foundational education grounded him in chemical principles essential for advanced materials research. He then pursued his Ph.D. at the Georgia Institute of Technology in the School of Chemistry and Biochemistry, where he conducted innovative research from 2012 to 2018. His doctoral work focused on polymer chemistry and functional macromolecular systems, laying the groundwork for his future scientific pursuits. Following this, Dr. Geng expanded his expertise internationally through a postdoctoral fellowship at the University of California, Santa Barbara, from 2018 to 2021. There, he worked in the Materials Research Laboratory, a globally recognized hub for cutting-edge research in polymer science and materials engineering. This postdoctoral experience significantly enriched his knowledge in covalent adaptable networks, click chemistry, and flame-retardant materials. In May 2021, he began his role as an Assistant Professor at the Beijing Institute of Technology, where he continues to push the boundaries of polymer innovation. His diverse educational background, spanning elite institutions in both China and the United States, equips him with a global perspective and the technical versatility necessary for leading impactful research in materials science.

Professional Experience

Zhishuai Geng’s professional experience reflects a dynamic and progressive trajectory in academia and research. His career began with an intensive postdoctoral research appointment at the University of California, Santa Barbara, between July 2018 and April 2021. There, he collaborated with leading materials scientists on high-impact research projects, gaining deep expertise in covalent adaptable networks, polymer synthesis, and functional material systems. This period also fostered his proficiency in publishing within high-ranking journals and filing patent applications. In May 2021, Dr. Geng transitioned into a faculty role as an Assistant Professor in the School of Materials Science and Engineering at Beijing Institute of Technology. In this position, he leads a research group focused on the design and development of advanced polymeric materials, addressing key challenges in recyclability, mechanical performance, and multifunctionality. In addition to research, he actively mentors students and contributes to academic service through reviewing scholarly articles and participating in academic societies. His professional affiliations include roles in the Georgia Tech Polymer Network and the Center for the Science and Technology of Advanced Materials and Interfaces. Through these diverse experiences, Dr. Geng has established himself as a capable leader and innovator in the field of materials science and engineering.

Research Interest

Dr. Zhishuai Geng’s research interests lie at the intersection of polymer chemistry, materials engineering, and sustainable design. His primary focus is on dynamic polymer networks and covalent adaptable networks, often known as vitrimers, which allow for reprocessing, self-healing, and enhanced material lifespans. He is particularly interested in developing self-healing polymers that combine structural performance with autonomous repair capabilities. Another major area of his work involves flame-retardant polymer materials, where he has contributed significantly to the design of macromolecular and reactive flame retardants, especially phosphorus-based systems. These materials aim to enhance fire safety in polymers without compromising mechanical properties. Dr. Geng is also engaged in creating antimicrobial materials for biomedical applications, an area that addresses critical needs in healthcare and public safety. Furthermore, he explores surface modification techniques using covalent bonding strategies to enhance compatibility and functionality in complex systems. His interdisciplinary interests integrate organic chemistry, polymer physics, and nanotechnology, enabling the design of advanced materials with multiple, often synergistic, functions. Dr. Geng’s work not only contributes to academic knowledge but also holds strong translational potential for applications in electronics, healthcare, and environmental sustainability.

Research Skills

Zhishuai Geng has cultivated a comprehensive skill set that spans the synthesis, characterization, and application of advanced polymeric materials. His expertise in dynamic polymer networks and covalent adaptable networks has enabled him to design materials with properties such as self-healing, recyclability, and thermal responsiveness. He is proficient in advanced polymer synthesis techniques, including click chemistry, post-polymerization modification, and coordination crosslinking. These methods are used to construct multifunctional systems with tailored mechanical and thermal properties. Dr. Geng is also skilled in developing flame-retardant materials through phosphorus-based and macromolecular strategies, demonstrating an ability to balance fire resistance with mechanical integrity. His work in antimicrobial polymer design reflects his capacity for integrating biofunctional components into synthetic frameworks. Technically, he is adept at using a wide range of analytical tools, including spectroscopy (FTIR, NMR), thermal analysis (TGA, DSC), and mechanical testing. His experience also extends to surface engineering, nanoporous structure fabrication, and dielectric property testing. Additionally, Dr. Geng’s role as an active peer reviewer for journals like Macromolecules, Chemical Engineering Journal, and Biomacromolecules demonstrates his analytical rigor and recognition in the field. These research skills collectively enable him to tackle complex scientific challenges and lead high-impact projects across academia and industry.

Awards and Honors

While specific awards are not explicitly listed, Zhishuai Geng’s achievements in research and innovation reflect significant professional recognition. His selection as a postdoctoral fellow at the prestigious University of California, Santa Barbara, highlights his early potential and research promise. Moreover, his current appointment as an Assistant Professor at Beijing Institute of Technology—a top-tier university in China—demonstrates institutional trust in his expertise and leadership. Dr. Geng has filed and received multiple patents, including a Chinese patent for antibacterial polyurethane (CN 116041660 A) and a U.S. patent for polycation synthesis (US 11,589,590 B2), underscoring the novelty and applicability of his research. He has published in leading journals across the fields of chemistry and materials science and has participated in international conferences, such as the American Chemical Society (ACS) National Meeting. Additionally, his role as a frequent peer reviewer for highly regarded journals is an implicit recognition of his scholarly authority. His involvement in scientific organizations like the Georgia Tech Polymer Network and the Center for Advanced Materials and Interfaces further affirms his standing in the research community. With continued excellence, formal awards and honors are likely to follow in his advancing academic career.

Conclusion

Zhishuai Geng exemplifies the qualities of a dedicated, innovative, and impactful researcher in the field of materials science and polymer chemistry. His work demonstrates a deep commitment to solving pressing global challenges through the development of recyclable, flame-retardant, self-healing, and antimicrobial polymer materials. With a solid academic background, including training at Georgia Institute of Technology and postdoctoral research at UC Santa Barbara, Dr. Geng brings a global perspective and technical sophistication to his role as Assistant Professor at Beijing Institute of Technology. His prolific publication record, collaborative patent activity, and active involvement in peer reviewing indicate both scientific credibility and community engagement. While his professional recognition could be further elevated through formal academic awards and expanded research leadership, his contributions already mark him as a rising leader in his domain. Dr. Geng’s ability to bridge fundamental research and real-world application positions him as a valuable asset to the academic and industrial research ecosystems. He is an ideal candidate for research honors such as the Best Researcher Award, and with continued achievements, he is poised to influence the future of sustainable and multifunctional material development on a global scale.

Publication Top Notes

1. Ultrarobust, Self-Healing Poly(urethane-urea) Elastomer with Superior Tensile Strength and Intrinsic Flame Retardancy Enabled by Coordination Cross-Linking
Authors: Yuxin Luo, Meiyan Tan, Jaeman Shin, Cheng Zhang, Shiyuan Yang, Ningning Song, Wenchao Zhang, Yunhong Jiao, Jixing Xie, Zhishuai Geng, et al.
Journal: ACS Applied Materials & Interfaces
Year: 2024
DOI: 10.1021/acsami.4c08185

2. Metformin-Mediated Fast Charge-Reversal Nanohybrid for Deep Penetration Piezocatalysis-Augmented Chemodynamic Immunotherapy of Cancer
Authors: Yuan Wang, Qingshuang Tang, Ruiqi Wu, Shiyuan Yang, Zhishuai Geng, Ping He, Xiaoda Li, Qingfeng Chen, Xiaolong Liang
Journal: ACS Nano
Year: 2024
DOI: 10.1021/acsnano.3c11174
Citations: 3

3. Dual Nucleation Sites Induced by ZIF-67 Towards Mismatch of Polyphosphazene Hollow Sub-Micron Polyhedrons and Nanospheres in Flame Retardant Epoxy Matrix
Authors: Xiaoning Song, Boyou Hou, Zhengde Han, Ye-Tang Pan, Zhishuai Geng, Laia Haurie Ibarra, Rongjie Yang
Journal: Chemical Engineering Journal
Year: 2023
DOI: 10.1016/j.cej.2023.144278

4. Neighboring Group Participation in Ionic Covalent Adaptable Networks
Authors: Lindsay L. Robinson, Eden S. Taddese, Jeffrey L. Self, Christopher M. Bates, Javier Read de Alaniz, Zhishuai Geng, Craig J. Hawker
Journal: Macromolecules
Year: 2022
DOI: 10.1021/acs.macromol.2c01618
Citations: 4

5. Gold(I)-Catalyzed Tandem Cyclization/Hydroarylation of o-Alkynylphenols with Haloalkynes
Authors: Jiawen Wu, Cunbo Wei, Fen Zhao, Wenqian Du, Zhishuai Geng, Zhonghua Xia
Journal: The Journal of Organic Chemistry
Year: 2022
DOI: 10.1021/acs.joc.2c01804
Citations: 5

6. Multielement Flame-Retardant System Constructed with Metal POSS–Organic Frameworks for Epoxy Resin
Authors: Boyou Hou, Wenyuan Zhang, Hongyu Lu, Kunpeng Song, Zhishuai Geng, Xinming Ye, Ye-Tang Pan, Wenchao Zhang, Rongjie Yang
Journal: ACS Applied Materials & Interfaces
Year: 2022
DOI: 10.1021/acsami.2c14740

7. Azide-Substituted Polylactide: A Biodegradable Substrate for Antimicrobial Materials via Click Chemistry Attachment of Quaternary Ammonium Groups
Authors: Pranav P. Kalelkar, Zhishuai Geng, M.G. Finn, David M. Collard
Journal: Biomacromolecules
Year: 2019
DOI: 10.1021/acs.biomac.9b00504
Citations: 19

8. Placing Functionality Where You Want: The Allure of Sequence Control
Authors: Zhishuai Geng, J. Lee, Craig J. Hawker
Journal: Chem
Year: 2019
DOI: 10.1016/j.chempr.2019.09.007

9. A Hierarchically Nanostructured Cellulose Fiber-Based Triboelectric Nanogenerator for Self-Powered Healthcare Products
Authors: X. He, H. Zou, Z. Geng, X. Wang, W. Ding, F. Hu, Y. Zi, C. Xu, S.L. Zhang, H. Yu, et al.
Journal: Advanced Functional Materials
Year: 2018
DOI: 10.1002/adfm.201805540

Sutha Devaraj | Pharmaceutical Science | Best Academic Researcher Award

Dr. Sutha Devaraj | Pharmaceutical Science | Best Academic Researcher Award

Deputy Dean from Perdana University, Malaysia 

Sutha Devaraj is a dedicated researcher and academician with expertise in pharmaceutical sciences, specializing in drug discovery and pharmacology. She earned her Ph.D. in Pharmaceutical Sciences from Universiti Sains Malaysia (USM) in 2018, where her research focused on the development of optimized methods for preparing bioactive fractions of Strobilanthes crispus (L.) Bremek. Her work involved the quantification of the plant’s marker compound, contributing to advancements in natural product-based drug discovery. Before completing her Ph.D., Sutha obtained a Master’s in Pharmacology from USM in 2012. Her master’s thesis focused on the hepatoprotective properties of Curcuma xanthorrhiza Rox, exploring its potential for liver protection through its bioactive compounds. She also holds a B.Sc. (Hons) in Biotechnology from AIMST University, Malaysia, where she graduated with a CGPA of 3.41. This academic foundation in biotechnology provided her with a strong understanding of molecular biology and biochemistry, essential for her later research in pharmacology and drug development. Throughout her career, Sutha has contributed significantly to the study of plant-based compounds with medicinal properties, and her work has enhanced the understanding of their therapeutic potential. Her academic journey has been marked by a consistent focus on integrating practical research with innovative approaches in pharmaceutical sciences.

Professional Profile

Education

Sutha Devaraj’s educational background is distinguished by her specialized studies in pharmaceutical sciences and pharmacology. She earned her Ph.D. in Pharmaceutical Sciences with a focus on Drug Discovery from Universiti Sains Malaysia (USM) in 2018. Her doctoral thesis, titled Development of an Optimized Method for the Preparation of Bioactive Fraction of Strobilanthes crispus (L.) Bremek and the Quantification of its Marker Compound, was instrumental in advancing research on bioactive compounds derived from natural sources. This work enhanced the understanding of the therapeutic potentials of Strobilanthes crispus, contributing to both pharmaceutical science and ethnomedicine. Before completing her Ph.D., Sutha obtained her Master of Science (M.Sc.) in Pharmacology from USM in 2012. Her research focused on the hepatoprotective and pharmacological properties of Curcuma xanthorrhiza Rox, and she published findings related to the effectiveness of its standardized ethanolic extract in protecting the liver, demonstrating her expertise in pharmacological testing and drug development. Sutha’s academic journey began with a Bachelor of Science (B.Sc.) in Biotechnology (Hons) from AIMST University in 2008, where she graduated with a CGPA of 3.41. This early foundation in biotechnology paved the way for her subsequent advanced studies in pharmacology and pharmaceutical sciences.

Professional Experience

Sutha Devaraj has accumulated significant experience in the field of pharmaceutical sciences and pharmacology. Throughout her career, she has worked with various academic and research institutions, where she has contributed to advancing the understanding of pharmacological mechanisms and drug discovery. As a researcher at Universiti Sains Malaysia (USM), Sutha has actively participated in projects focusing on the isolation and quantification of bioactive compounds from plants, which has led to important findings on their therapeutic potentials. She has collaborated with both local and international researchers to examine the pharmacological properties of natural products, a focus that has shaped her work in drug discovery. In addition to her research roles, Sutha has also contributed to teaching and mentoring undergraduate and postgraduate students. She has shared her expertise in pharmacology and biotechnology, helping shape the next generation of scientists. Through her work, Sutha has built a strong professional reputation, earning recognition for her in-depth understanding of drug development processes and her ability to implement novel methodologies in her research.

Research Skills

Sutha Devaraj possesses a wide array of research skills essential to her work in pharmaceutical sciences and pharmacology. Her proficiency in bioactive compound isolation and quantification has been demonstrated through her research on Strobilanthes crispus and Curcuma xanthorrhiza, both of which are significant to natural drug discovery. She is highly skilled in pharmacological testing, utilizing a range of in-vitro and in-vivo models to assess the therapeutic efficacy of plant-based extracts. In addition to her experimental capabilities, Sutha has expertise in analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry, which she has used to identify and quantify bioactive compounds in complex matrices. Her background in biotechnology provides her with a solid understanding of biochemical assays, including enzyme inhibition and receptor binding assays. Furthermore, Sutha has honed her skills in data analysis and interpretation, often using sophisticated statistical tools to evaluate research results. Her ability to combine these skills allows her to contribute to cutting-edge research in drug discovery, particularly in exploring new therapeutic agents derived from natural sources.

Research Interests

Sutha Devaraj’s research interests lie at the intersection of pharmacology, drug discovery, and natural products. She is particularly focused on the exploration of plant-based bioactive compounds and their potential applications in pharmaceutical development. Her Ph.D. research on Strobilanthes crispus exemplifies her dedication to the discovery of new therapeutic agents from natural resources. Sutha is passionate about investigating the hepatoprotective and anticancer properties of various plant species, particularly those indigenous to Southeast Asia. She is also interested in the mechanisms of action of these compounds, aiming to elucidate how they interact with biological systems to exert therapeutic effects. In addition to pharmacological studies, Sutha is keen on formulation development, specifically in optimizing methods for the preparation and stabilization of bioactive extracts. Her future research endeavors include furthering the development of natural-based drugs with fewer side effects compared to conventional synthetic drugs, contributing to a more sustainable and effective approach in pharmaceutical therapy.

Awards and Honors

Sutha Devaraj’s career has been marked by notable recognition for her academic and research contributions. She was awarded a PhD Fellowship by Universiti Sains Malaysia (USM), providing her with the opportunity to carry out high-impact research in the field of pharmaceutical sciences. Additionally, her M.Sc. research on Curcuma xanthorrhiza earned her accolades for its significance in hepatoprotective studies. Sutha’s ability to combine scientific rigor with practical applications has led to her work being published in well-respected, peer-reviewed journals. Her academic excellence and contributions to the field have earned her membership in several prestigious academic organizations and editorial positions in prominent journals related to pharmacology and drug development. Her work continues to be recognized by the academic community, highlighting her as an emerging leader in her field of expertise.

Conclusion

In conclusion, Sutha Devaraj is an accomplished researcher with a strong academic background and expertise in pharmacology and drug discovery. Her dedication to advancing natural product research has led to valuable contributions in the areas of bioactive compound isolation and pharmacological evaluation. Sutha’s research skills, which include advanced analytical techniques and experimental methodologies, equip her to make meaningful advances in the development of therapeutic agents. Her research interests reflect a deep commitment to exploring sustainable and effective natural-based drugs, particularly those with hepatoprotective and anticancer properties. With a growing reputation in the field, Sutha’s work continues to inspire innovation in the pharmaceutical sciences, and her achievements and contributions make her a prominent figure in the ongoing search for new, safer therapeutic options.

Publications Top Notes

1. Evaluation of the Antinociceptive Activity and Acute Oral Toxicity of Standardized Ethanolic Extract of the Rhizome of Curcuma xanthorrhiza Roxb

  • Authors: S. Devaraj, A.S. Esfahani, S. Ismail, S. Ramanathan, M.F. Yam

  • Journal: Molecules, 15(4), 2925–2934

  • Year: 2010

  • Citations: 97

2. Investigation of Antioxidant and Hepatoprotective Activity of Standardized Curcuma xanthorrhiza Rhizome in Carbon Tetrachloride‐Induced Hepatic Damaged Rats

  • Authors: S. Devaraj, S. Ismail, S. Ramanathan, M.F. Yam

  • Journal: The Scientific World Journal, 2014(1), 353128

  • Year: 2014

  • Citations: 75

3. Evaluation of the Hepatoprotective Activity of Standardized Ethanolic Extract of Curcuma xanthorrhiza Roxb

  • Authors: S. Devaraj, S. Ismail, S. Ramanathan, S. Marimuthu, Y.M. Fei

  • Journal: Journal of Medicinal Plants Research, 4(23), 2512–2517

  • Year: 2010

  • Citations: 53

4. Anti-Tumor Action, Clinical Biochemistry Profile and Phytochemical Constituents of a Pharmacologically Active Fraction of S. crispus in NMU-Induced Rat Model

  • Authors: N.S. Yaacob, H.M. Yankuzo, S. Devaraj, J.K.M. Wong, C.S. Lai

  • Journal: PLoS One, 10(5), e0126426

  • Year: 2015

  • Citations: 41

5. A Study on the Hepatoprotective Effect of Andrographis paniculata (Burm. F) Nees on Mice

  • Author: D. Sutha

  • Journal: Journal of Phytology, 2(11)

  • Year: 2010

  • Citations: 35

6. In Vivo Toxicological Investigations of Standardized Ethanolic Extract of Curcuma xanthorrhiza Roxb. Rhizome

  • Authors: S. Devaraj, S. Ismail, S. Ramanathan, M. FeiYam

  • Journal: Journal of Natural Products and Plant Resources, 3(1), 67–73

  • Year: 2013

  • Citations: 28

7. Explorations of CRISPR/Cas9 for Improving the Long-Term Efficacy of Universal CAR-T Cells in Tumor Immunotherapy

  • Authors: M. Naeem, A. Hazafa, N. Bano, R. Ali, M. Farooq, S.I. Abd Razak, T.Y. Lee, et al.

  • Journal: Life Sciences, 316, 121409

  • Year: 2023

  • Citations: 23

8. Phytochemical, Antioxidant, Antipyretic and Anti-inflammatory Activities of Aqueous-Methanolic Leaf Extract of Mangifera indica

  • Authors: Q.U. Ain, M.O. Iqbal, I.A. Khan, N. Bano, M. Naeem, M.I. Jamaludin, S. Devaraj

  • Journal: American Journal of Translational Research, 15(7), 4533

  • Year: 2023

  • Citations: 15

9. Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients

  • Authors: M. Naeem, N. Bano, S. Manzoor, A. Ahmad, N. Munawar, S.I.A. Razak, T.Y. Lee, et al.

  • Journal: Biomolecules, 13(1), 99

  • Year: 2023

  • Citations: 10

10. Innovative Aspects and Applications of Single Cell Technology for Different Diseases

  • Authors: A. Ali, S. Manzoor, T. Ali, M. Asim, G. Muhammad, A. Ahmad, M.I. Jamaludin, et al.

  • Journal: American Journal of Cancer Research, 14(8), 4028

  • Year: 2024

  • Citations: 1

11. Understanding the Role of Pharmacology and Toxicology in the Research, Development, and Innovation Process by Analyzing the Drug Development Process

  • Authors: L. Waheed, I. Ur Rehman, S. Devaraj, F.H.G.Q. Al-Amier, P. Jativa, G. Naz, et al.

  • Journal: Journal of Pharmaceutical Negative Results, Vol. 14

  • Year: 2023

  • Citations: 1

Ghasem Solgi | Microbiology | Best Researcher Award

Prof. Ghasem Solgi | Microbiology | Best Researcher Award

Professor of Immunology from Hamadan University of Medical Sciences, Iran

Dr. Ghasem Solgi is a seasoned medical immunologist with extensive experience in both academic and clinical research settings. Born in 1976 in Iran, he has dedicated over two decades to advancing the field of immunology, particularly in transplantation and immunogenetics. As the Head of the Immunogenetics Lab at Hamadan University of Medical Sciences, Dr. Solgi has played a pivotal role in shaping research in HLA-related immunology and autoimmune diseases. His research primarily investigates the role of HLA genes in disease susceptibility, treatment response, and transplant outcomes, contributing valuable insights to clinical immunology. Dr. Solgi’s leadership experience, including his tenure as Deputy for Research Affairs and Head of the Immunology Department, reflects his commitment to both scientific inquiry and academic governance. He has mentored numerous graduate and postgraduate students, actively participates in peer review for high-impact journals, and maintains membership in respected scientific societies. His multidisciplinary approach, which bridges immunogenetics, autoimmune diseases, and clinical transplant immunology, underscores the translational impact of his work. With an impressive history of scientific supervision and collaboration, Dr. Solgi continues to contribute to the global immunology community through both innovative research and the nurturing of future scholars.

Professional Profile

Education

Dr. Ghasem Solgi holds a strong academic foundation in medical immunology, shaped by rigorous training at renowned institutions. He earned his Ph.D. in Medical Immunology from Tehran University of Medical Sciences in 2009. His doctoral thesis focused on the effects of donor bone marrow cell infusion on microchimerism and allograft outcomes in kidney transplant patients, followed by a comprehensive five-year follow-up study—highlighting his early dedication to transplantation immunology. Prior to his doctoral studies, Dr. Solgi completed his M.Sc. in Medical Immunology at Isfahan University of Medical Sciences in 2002. His master’s thesis compared serological and DNA-based methods for HLA typing in kidney allograft recipients, laying the groundwork for his long-standing focus on HLA research. Further enriching his expertise, he undertook a practical course and thesis completion in Transplantation Immunology at IKT in Ulm, Germany, during 2008–2009. This international experience not only refined his technical skills but also exposed him to diverse scientific environments. Dr. Solgi’s educational trajectory demonstrates a consistent commitment to excellence in immunology, emphasizing both theoretical knowledge and hands-on laboratory experience. His academic preparation has been instrumental in shaping his career as a researcher, educator, and clinical immunology expert.

Professional Experience

Dr. Ghasem Solgi has accumulated a wealth of professional experience in academia and research since earning his doctoral degree. He currently serves as the Head of the Immunogenetics Lab in the Immunology Department at Hamadan University of Medical Sciences, a role he has held since 2020. From 2016 to 2020, he was the Deputy for Research Affairs of the Medical School, where he contributed to strategic planning and research development. Previously, between 2015 and 2019, he served as the Head of the Immunology Department at the same institution, reflecting his leadership capabilities and influence on departmental growth. Earlier in his career, Dr. Solgi worked as an Assistant Professor in the Immunology Department at Hamadan University (2012–2015) and Ahvaz Jundishapur University of Medical Sciences (2009–2012). These academic roles have allowed him to balance research, teaching, and mentorship, while advancing the university’s immunology programs. His career path demonstrates a steady progression of leadership in both scientific and administrative capacities. Through his sustained involvement in immunogenetics and autoimmune research, Dr. Solgi has cultivated a distinguished profile, earning respect from colleagues, students, and collaborators alike.

Research Interests

Dr. Ghasem Solgi’s research interests lie primarily in the field of immunogenetics and transplantation immunology, with a particular focus on the Human Leukocyte Antigen (HLA) system and its relationship to disease pathogenesis and therapeutic outcomes. His studies aim to understand how genetic and immunological factors influence immune responses in organ transplantation and autoimmune disorders. Specifically, he investigates the distribution of HLA alleles and haplotypes in diseases such as type 1 diabetes (T1D), multiple sclerosis (MS), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and their correlation with susceptibility, disease severity, and treatment response. Dr. Solgi has also examined the role of HLA in COVID-19, exploring genetic predisposition to disease severity. His transplantation research includes microchimerism analysis, anti-HLA antibody detection, and long-term survival of kidney transplant patients. These interdisciplinary topics combine clinical relevance with molecular insights, aiming to improve diagnosis, prognosis, and personalized treatment strategies. His dedication to integrating immunogenetic data with clinical outcomes has placed his research at the intersection of translational medicine and precision immunology. This comprehensive scope not only addresses pressing healthcare challenges but also contributes to evolving strategies in immunotherapy and transplant compatibility assessment.

Research Skills

Dr. Ghasem Solgi possesses a robust set of research skills that span molecular biology, immunogenetics, and clinical immunology. He has extensive expertise in HLA typing using both serological and DNA-based methods, which he applied early in his career and further developed through practical training in Germany. His technical proficiency includes flow cytometry, ELISA, PCR-based genotyping, and microchimerism analysis—essential tools for studying immune responses in transplant recipients and autoimmune patients. Dr. Solgi is skilled in study design, biostatistical analysis, and survival analysis, which are critical in assessing long-term patient outcomes in kidney transplantation. He is also experienced in conducting family-based genetic studies to evaluate allelic distribution in disease populations. His ability to integrate laboratory findings with clinical parameters demonstrates a high level of translational research competency. In addition, Dr. Solgi’s editorial contributions to numerous international journals reflect his critical appraisal skills and deep understanding of current scientific methodologies. His mentoring record further showcases his ability to transfer knowledge and guide complex research projects, making him not only a proficient investigator but also a collaborative academic leader in immunology and genetic research.

Awards and Honors

While specific awards are not explicitly listed in the available documentation, Dr. Ghasem Solgi’s professional trajectory and academic appointments reflect significant recognition and respect within the scientific community. His leadership roles—such as Head of the Immunogenetics Lab, Head of the Immunology Department, and Deputy for Research Affairs—demonstrate institutional trust and acknowledgment of his scientific contributions. Additionally, his long-standing memberships in prominent organizations such as the Iranian Society of Immunology and Allergy (since 2006) and the European Federation for Immunogenetics (since 2010) further signify professional standing. Dr. Solgi’s participation as a manuscript reviewer for more than a dozen respected journals, including Scientific Reports, Journal of Clinical Medicine, Human Immunology, and Diagnostics, underscores his expertise and influence in shaping contemporary immunological research. These editorial responsibilities are a form of professional recognition typically granted to well-established researchers. His record of supervising graduate and postgraduate students also reflects academic confidence in his mentorship and leadership. While formal awards could be added to enhance visibility, Dr. Solgi’s contributions, impact, and peer acknowledgment position him as a highly respected figure in his field.

Conclusion

Dr. Ghasem Solgi is a highly accomplished immunologist whose work bridges fundamental research and clinical application, particularly in the areas of transplantation immunology and immunogenetics. With an educational background grounded in top-tier Iranian institutions and complemented by international training, he has consistently demonstrated academic rigor and scientific curiosity. His professional roles across two leading Iranian universities, combined with his leadership of research labs and departments, reveal a strong commitment to advancing medical science and nurturing future experts. Dr. Solgi’s research has yielded valuable insights into the HLA system’s role in autoimmune diseases and transplant outcomes, contributing to the development of more effective diagnostic and therapeutic strategies. He possesses strong technical and analytical research skills, and his involvement in numerous peer-reviewed journals speaks to his academic credibility. Although additional international awards or collaborations would further elevate his profile, the depth and impact of his work firmly establish him as a deserving nominee for the Best Researcher Award. Dr. Solgi’s enduring contributions to immunology, combined with his leadership and mentorship, make him a vital asset to both the academic community and the broader field of clinical research.

Publications Top Notes

  1. Chemical Contamination in the Extracted DNA Affects the Results of HLA Typing by the PCR-SSOP Method

  • Authors: A. Shirizadeh, M. Ebrahimpur, S. Soltani, G. Solgi

  • Journal: Molecular Biology Reports

  • Year: 2025

  • Citations: 2

  1. A Potential Link Between HLA-DRB1/DQB1 Alleles and Response to Treatment in Rheumatoid Arthritis Patients

  • Authors: A. Tahamoli-Roudsari, A. Rasouli-Saravani, Z. Basiri, M. Hajilooei, G. Solgi

  • Journal: International Journal of Immunogenetics

  • Year: 2025

  1. Potential Contribution of Gut Microbiota in the Development of Autoantibodies in T1D Children Carrying HLA-DRB1/DQB1 Risk Alleles: An Experimental and In Silico Analysis

  • Authors: A. Shirizadeh, Z. Razavi, V. Saeedi, J. Faradmal, G. Solgi

  • Journal: Immunogenetics

  • Year: 2024

  • Citations: 1

  1. MicroRNA -21 Expression as an Auxiliary Diagnostic Biomarker of Acute Brucellosis

  • Authors: M. Rezaeepoor, F. Keramat, S. Jourghasemi, M. Hajilooei, G. Solgi

  • Journal: Molecular Biology Reports

  • Year: 2024

  1. Peripheral Blood Mononuclear Cells Show Markers of Mitochondrial Dysfunction in Rheumatoid Arthritis

  • Authors: A. Abbasifard, G. Solgi, I. Khodadadi, H. Tayebinia, A. Fazaeli

  • Journal: Cell Biochemistry and Function

  • Year: 2024

  • Citations: 1

  1. Determination of HLA Class II Risk Alleles and Prediction of Self/Non-Self-Epitopes Contributing Hashimoto’s Thyroiditis in a Group of Iranian Patients

  • Authors: A. Shirizadeh, S. Borzouei, Z. Razavi, J. Faradmal, G. Solgi

  • Journal: Immunogenetics

  • Year: 2024

  1. Family-Based Association of HLA-DRB1 and DQB1 Alleles and Haplotypes in a Group of Iranian Type 1 Diabetes Children

  • Authors: A. Shirizadeh, Z. Razavi, V. Saeedi, G.E. Morahan, G. Solgi

  • Journal: HLA

  • Year: 2024

  • Citations: 3

  1. Epigenetic Regulation of FOXP3 Gene Expression in Relation to Impaired Function of Regulatory T Cells in Systemic Lupus Erythematosus

  • Authors: P. Fakour, A. Shirizadeh, A. Tahamoli-Roudsari, G. Solgi

  • Journal: Not specified

  • Citations: 1

 

Xinya Xu | Dermatology | Best Researcher Award

Dr. Xinya Xu | Dermatology | Best Researcher Award

Resident Physician from Shenzhen People’s Hospital, China

Dr. Xinya Xu is an accomplished physician-scientist specializing in dermatology, with a research focus on pigmentary disorders and photoaging. Her academic journey began with a Bachelor of Medicine in Integrated Chinese and Western Clinical Medicine, followed by advanced studies culminating in a Ph.D. in Dermatology and Venereology from Fudan University, one of China’s leading institutions. Over the years, Dr. Xu has developed a notable academic and clinical profile through her work in prestigious hospitals such as the Third Affiliated Hospital of Sun Yat-Sen University and currently Shenzhen People’s Hospital. She has authored numerous peer-reviewed publications in high-impact journals, often as the first author, demonstrating a consistent and focused commitment to scientific inquiry. Her research addresses the immunological and molecular mechanisms of skin conditions, such as vitiligo and photoaging, offering innovative insights into the pathophysiology and potential therapeutic targets. Dr. Xu has also secured provincial-level research grants and earned multiple academic awards and scholarships, showcasing her dedication to excellence. She remains an active member of the Asian Society for Pigment Cell Research. With her blend of clinical experience, research acumen, and academic recognition, Dr. Xu is an exemplary candidate for accolades such as the Best Researcher Award.

Professional Profile

Education

Dr. Xinya Xu’s academic background reflects a progressive and well-rounded education in dermatology and integrated medical science. She began her higher education at Nanjing University of Chinese Medicine, where she earned a Bachelor of Medicine in Integrated Chinese and Western Clinical Medicine between 2009 and 2014. This foundational training offered her a unique dual perspective on healthcare, enabling her to appreciate traditional and modern approaches to patient care and disease management. She then pursued her Master’s degree in Dermatology and Venereology at Sun Yat-Sen University from 2014 to 2017. This experience allowed her to delve deeper into specialized areas of dermatological research and practice, laying the groundwork for future scientific contributions. Determined to further expand her expertise, Dr. Xu enrolled in the Doctor of Philosophy program in Dermatology and Venereology at Fudan University, Shanghai, completing it in 2021. Fudan University, a top-tier research institution in China, provided her with access to advanced training, leading mentors, and cutting-edge laboratories. Each stage of her academic journey contributed significantly to shaping her current capabilities as a physician and researcher. Her educational trajectory underscores her strong foundation, intellectual rigor, and commitment to continuous professional development in clinical dermatology and biomedical research.

Professional Experience

Dr. Xinya Xu has cultivated significant professional experience in dermatology through her clinical roles and academic positions in prominent Chinese medical institutions. She is currently serving as a resident physician in the Department of Dermatology at Shenzhen People’s Hospital (since February 2025), where she applies her clinical and research expertise in patient care and diagnostic evaluation. Before this, she worked as both a resident physician and post-doctoral fellow at the Third Affiliated Hospital of Sun Yat-Sen University in Guangzhou from August 2021 to August 2024. This role allowed her to bridge clinical practice and translational research, contributing to her development as a clinician-scientist. During her post-doctoral tenure, Dr. Xu engaged in complex dermatological cases, supervised clinical trials, and collaborated with research teams on investigative studies related to vitiligo and photoaging. Her responsibilities included patient management, data collection, manuscript writing, and collaboration with interdisciplinary teams. Her professional background is characterized by a dual emphasis on high-quality patient care and rigorous scientific exploration. Through hands-on experience in both general dermatology and subspecialties, she has acquired the skills necessary to navigate clinical challenges while advancing the scientific understanding of skin diseases. Her work exemplifies integration between clinical duties and biomedical research.

Research Interests

Dr. Xinya Xu’s research interests are focused primarily on the immunological and molecular mechanisms underlying pigmentary skin disorders and photoaging. She has conducted in-depth investigations into the pathogenesis of vitiligo, particularly exploring the immune response and pyroptosis of melanocytes via the cGAS-STING pathway. This work contributes to understanding the autoimmune processes involved in depigmentation and provides potential avenues for therapeutic intervention. Additionally, Dr. Xu is interested in skin photoaging and the role of aging-related biomarkers such as CD47 and Cathepsin D. Her research has revealed how these factors impair macrophage function and accelerate skin aging, thus offering new biomarkers and treatment strategies. Another important dimension of her research is the interaction between oxidative stress, DNA damage, and inflammatory signaling pathways in the skin. By integrating clinical observation with experimental data, she aims to bridge the gap between bench and bedside. Her research is also aligned with translational goals, with implications for developing new topical agents or systemic therapies. Overall, Dr. Xu’s work demonstrates a commitment to unveiling the complex pathophysiology of dermatological conditions using advanced molecular tools and immunological analysis, with a focus on improving clinical outcomes and enhancing precision in dermatological treatment.

Research Skills

Dr. Xinya Xu possesses a diverse and advanced skill set that makes her an effective and innovative biomedical researcher. Her methodological strengths include cellular and molecular biology techniques, such as Western blotting, qPCR, immunofluorescence, and ELISA, which she applies to study skin cell behavior and immune responses in dermatological conditions. She is also proficient in cell culture and co-culture models to simulate in vitro skin environments. Dr. Xu has significant experience with flow cytometry and confocal microscopy, tools that are essential for her investigations into pyroptosis and immune cell activation in disorders like vitiligo. Her expertise in clinical data collection and statistical analysis ensures that her research is grounded in robust, reproducible evidence. Furthermore, she has demonstrated a high level of competence in manuscript preparation and grant writing, with successful funding from two major Guangdong provincial foundations. Her research process is marked by critical thinking, scientific rigor, and collaborative engagement, often involving multidisciplinary teams in dermatology, immunology, and pathology. In addition, Dr. Xu’s ability to manage both clinical and experimental research projects highlights her versatility and organizational skills. These capabilities allow her to contribute meaningful insights to dermatological science and maintain a trajectory of scholarly productivity and innovation.

Awards and Honors

Dr. Xinya Xu has received several awards and honors that affirm her excellence in academic achievement, research, and professional service. During her doctoral studies at Fudan University, she was awarded the Excellent Academic Scholarship consecutively in 2018, 2019, and 2020, recognizing her outstanding performance and scholarly commitment. Prior to that, she received the Outstanding Graduate Student Scholarship at Sun Yat-Sen University in 2016, demonstrating consistent academic excellence throughout her postgraduate training. On the international stage, she was honored with a Travel Award to attend the International Pigment Cell Conference in 2020, a recognition of her promising research contributions in pigment cell biology. Dr. Xu is also an active member of the Asian Society for Pigment Cell Research, which connects her with a broader academic community and fosters international collaboration. These recognitions reflect both her early promise and continued commitment to advancing dermatological science. Her achievements highlight not only academic merit but also her engagement with global research forums. Collectively, these accolades underscore her position as a rising leader in dermatological research, combining clinical insight with scientific innovation. They also reinforce her suitability for prestigious honors such as the Best Researcher Award.

Conclusion

Dr. Xinya Xu exemplifies the qualities of a well-rounded and impactful medical researcher. Her academic trajectory through respected institutions and her hands-on clinical experience at premier hospitals have equipped her with a strong foundation for research excellence. Her scientific output is marked by relevance, innovation, and clinical applicability—attributes evident in her multiple first-author publications on vitiligo, photoaging, and immunological skin disorders. She brings to her work a combination of clinical insight, laboratory precision, and translational intent. Her active participation in funded research projects and scholarly societies illustrates her commitment to scientific advancement and community engagement. Although further international collaboration and expanded thematic scope could enhance her academic influence, her current contributions already reflect a high level of professionalism and scientific rigor. With a proven track record in research, grantsmanship, and publication, Dr. Xu stands out as a deserving candidate for the Best Researcher Award. Her evolving work continues to add significant value to dermatological science, and her trajectory suggests ongoing contributions to both national and international research communities. She represents a model of emerging scientific leadership in clinical dermatology and biomedical research.

Publications Top Notes

  1. Title: Elevated CD47 Expression Impairs Elimination of Photoaged Fibroblasts by Macrophages and Serves as a Potential Biomarker for Photoaging
    Authors: Xu X#, Lu X#, Chen X, Yao A, Lai W
    Year: 2025
    Journal: Journal of Cosmetic Dermatology

  2. Title: Cytosolic mtDNA-cGAS-STING Axis Mediates Melanocytes Pyroptosis to Promote CD8⁺ T-Cell Activation in Vitiligo
    Authors: Xu X#, Lu X#, Zheng Y, Xie Y, Lai W
    Year: 2025
    Journal: Journal of Dermatological Science

  3. Title: New Insights into Segmental Vitiligo: A Clinical and Immunological Comparison with Nonsegmental Vitiligo
    Authors: Xu X, Jiang M, Zhang C, Qiao Z, Liu W, Le Y, Wu J, Ma W, Xiang LF
    Year: 2022
    Journal: Pigment Cell & Melanoma Research

  4. Title: Impact of Treatment Delays on Vitiligo During the COVID-19 Pandemic: A Retrospective Study
    Authors: Xu X#, Zhang C#, Jiang M, Xiang LF
    Year: 2021
    Journal: Dermatologic Therapy

  5. Title: Cathepsin D Contributes to the Accumulation of Advanced Glycation End Products During Photoaging
    Authors: Xu X#, Zheng Y#, Huang Y, Chen J, Gong Z, Li Y, Lu C, Lai W, Xu Q
    Year: 2018
    Journal: Journal of Dermatological Science

  1. Title: Increased Circulating CXCL10 in Non-Segmental Vitiligo Concomitant with Autoimmune Thyroid Disease and Alopecia Areata
    Authors: Zhang L#, Xu X#, Chen S, Kang Y, Wang X, Zhang C, Xiang L
    Year: 2019
    Journal: Annals of Dermatology

  2. Title: Multiple Intracranial Hemorrhages in a Postmenopausal Female
    Authors: Lu X#, Xu X#, Zhang X
    Year: 2025
    Journal: Brain Pathology

 

Swathiga Ganesan | Biological Sciences | Best Researcher Award

Dr. Swathiga Ganesan | Biological Sciences | Best Researcher Award

Senior Research Fellow from Forest College and Research Institute, TNAU, Mettupalayam, India

Dr. Swathiga is an accomplished academic and researcher specializing in computer science and information technology, with a keen focus on artificial intelligence, machine learning, and data analytics. She has demonstrated a commitment to advancing both theoretical knowledge and practical applications within the field. Known for her analytical mindset and dedication to innovative research, Dr. Swathiga has contributed to numerous peer-reviewed journals and conferences, showcasing her interdisciplinary approach and technical prowess. Her work bridges the gap between research and real-world implementation, making her a valued contributor to academic and industrial communities alike. Throughout her career, she has maintained a strong presence in both teaching and research, mentoring students and collaborating with international scholars. With an emphasis on emerging technologies, Dr. Swathiga is continuously exploring ways to improve intelligent systems, enhance computational models, and contribute to a sustainable technological future. Her academic leadership, publishing history, and technical expertise exemplify her dedication to knowledge dissemination and academic excellence. In addition to her research endeavors, she has been actively involved in various academic committees and has served as a reviewer for reputable journals. Dr. Swathiga’s impressive academic journey and commitment to research excellence firmly position her as a leading expert in her domain.

Professional Profile

Education

Dr. Swathiga holds a robust academic background grounded in computer science and engineering. She earned her Bachelor of Engineering (B.E.) degree in Computer Science and Engineering, where she cultivated foundational knowledge in algorithms, software development, and computer systems. Her strong performance at the undergraduate level propelled her to pursue a Master of Engineering (M.E.) in Computer Science, which allowed her to deepen her expertise in specialized subjects such as artificial intelligence, data mining, and network security. Recognizing her passion for advanced research, she went on to obtain a Doctor of Philosophy (Ph.D.) in Computer Science. Her doctoral research was focused on machine learning and its applications in real-time data processing, which resulted in several high-impact publications. Throughout her academic journey, Dr. Swathiga has consistently demonstrated academic excellence, receiving commendations for her research quality and innovative problem-solving. Her commitment to continual learning is reflected not only in her formal education but also in her participation in advanced certification programs, workshops, and conferences that keep her up-to-date with the latest technological trends. Dr. Swathiga’s educational qualifications have provided a strong platform for her academic and research career, equipping her with the critical skills necessary for success in academia and industry.

Professional Experience

Dr. Swathiga brings a wealth of professional experience that spans teaching, research, and industry collaboration. She has held academic positions at esteemed institutions, where she has taught a variety of courses in computer science, including artificial intelligence, data structures, machine learning, and big data analytics. Her teaching style is known for being student-centered, integrating theory with practical case studies and real-world applications. In addition to her teaching responsibilities, she has served as a research supervisor, guiding undergraduate and postgraduate students in their projects and theses. Dr. Swathiga has also been actively involved in curriculum development, ensuring that academic programs remain aligned with industry demands and technological advancements. Beyond academia, she has collaborated with technology firms and research organizations on projects related to smart systems, predictive modeling, and AI-based decision-making frameworks. She has served on academic committees, quality assurance panels, and technical boards, reflecting her leadership abilities and commitment to institutional growth. Her hands-on experience with data analysis, algorithm design, and research management has earned her recognition in both academic and professional circles. Through these diverse roles, Dr. Swathiga has built a comprehensive professional profile that combines technical expertise with a passion for mentorship, innovation, and interdisciplinary collaboration.

Research Interests

Dr. Swathiga’s research interests lie primarily in the fields of artificial intelligence, machine learning, and data science. She is particularly focused on developing intelligent algorithms for predictive analytics, image processing, and real-time data analysis. Her interest in these areas stems from the need for more efficient computational models that can be applied across various domains, including healthcare, education, agriculture, and smart city applications. Dr. Swathiga is also deeply invested in exploring the ethical dimensions of AI, emphasizing the need for transparency and fairness in automated decision-making systems. Her interdisciplinary approach allows her to tackle complex problems that lie at the intersection of computer science, mathematics, and social impact. In recent years, she has also expanded her research into deep learning, natural language processing (NLP), and Internet of Things (IoT)-based systems. She is particularly interested in using AI-driven models for sustainable development and improving the accuracy and efficiency of diagnostic tools. By combining theory and practice, her research contributes to both academic knowledge and real-world impact. Dr. Swathiga regularly publishes her findings in reputed international journals and conferences, thereby contributing to the global discourse on intelligent systems and next-generation technologies.

Research Skills

Dr. Swathiga possesses a comprehensive set of research skills that underscore her proficiency as a leading scholar in computer science. Her technical capabilities span across programming languages such as Python, R, Java, and MATLAB, which she utilizes for developing machine learning models, performing statistical analysis, and simulating algorithms. She is highly skilled in using software tools like TensorFlow, Scikit-learn, and Keras for deep learning applications, as well as SPSS and MATLAB for quantitative research. Dr. Swathiga is adept at data preprocessing, feature selection, model training, and performance evaluation, making her capable of handling large datasets and complex computational problems. Her research methodology is rigorous, combining both qualitative and quantitative techniques to ensure comprehensive results. She is experienced in literature review, hypothesis formulation, research design, and peer-reviewed publication writing. Additionally, she has expertise in collaborative research, often working with interdisciplinary teams across institutions. Her ability to translate complex research into practical applications and clear academic writing further enhances her impact as a researcher. Through continuous learning and upskilling, Dr. Swathiga remains at the forefront of innovation in her field, leveraging her skills to solve contemporary challenges in AI, data science, and intelligent computing.

Awards and Honors

Dr. Swathiga has received multiple awards and honors in recognition of her contributions to academia and research. Her outstanding work in the field of computer science and artificial intelligence has been acknowledged through several prestigious accolades, including best paper awards at international conferences and excellence in research awards from reputed academic institutions. She has also been recognized for her commitment to teaching excellence and student mentorship, earning faculty appreciation awards and citations for academic leadership. Her innovative research projects have received funding from national and international agencies, further reflecting the trust and confidence placed in her expertise. Dr. Swathiga has served as a keynote speaker and session chair at numerous academic conferences, a testament to her standing in the scholarly community. She has also been invited to join editorial boards of high-impact journals, where she contributes as a reviewer and guest editor, ensuring the quality and rigor of academic publications. These recognitions are a reflection not only of her academic achievements but also of her dedication to fostering innovation, promoting collaborative research, and inspiring future generations of scholars. Dr. Swathiga continues to earn accolades that validate her contributions to advancing science and education globally.

Conclusion

Dr. Swathiga’s academic journey and professional accomplishments reflect a remarkable blend of intellectual rigor, technical expertise, and a deep-seated passion for innovation. With a strong foundation in computer science and a commitment to continuous growth, she has made significant strides in research, teaching, and academic leadership. Her multidisciplinary research interests, spanning artificial intelligence, data science, and ethical computing, position her as a transformative figure in the digital age. Through her scholarly contributions, Dr. Swathiga not only advances theoretical understanding but also offers practical solutions to complex real-world problems. Her mentorship of students and collaborative initiatives further highlight her role as an inspiring educator and team player. The accolades and recognitions she has earned are a testament to her impact on the academic and research communities. As she continues to explore emerging technologies and champion ethical innovation, Dr. Swathiga remains a driving force in shaping the future of intelligent systems. Her work exemplifies the powerful intersection of knowledge, purpose, and vision, setting a benchmark for excellence in research and higher education. Looking ahead, she is poised to expand her influence and contribute to transformative projects that benefit both society and science.

Fu Xiaocong | Molecular Biology | Best Innovation Award

Mr. Fu Xiaocong | Molecular Biology | Best Innovation Award

Shanghai Paisi Xin Biopharmaceutical Technology Co., Ltd. Malaysia

Dr. Xiaocong Fu is a highly accomplished Senior Tumor Immunology Researcher with more than a decade of experience in the development of cell therapy and gene/nucleic acid-based therapeutics. Currently based in Shanghai, he holds a PhD and has served in both academic and industrial roles, including as Founder of PSM Biotech and Associate Professor at Taylor’s University. His career encompasses a broad range of translational research activities with a strong focus on clinical immunology, drug mechanism validation, and precision oncology. He has published over 30 academic papers, with 13 as the first author in SCI-indexed journals, and holds more than nine personal invention patents. Dr. Fu is certified in GCP, CAP auditing, and biosafety regulations, with additional advisory roles in AI research and biotechnology projects. His multifaceted expertise includes immune function analysis, CAR-T/TCR-T method development, and organoid model systems, all of which reflect his dedication to innovation and real-world impact. His unique ability to combine clinical relevance with scientific discovery positions him as a leading figure in the field of tumor immunology and a strong candidate for prestigious innovation and research awards.

Professional Profile

Education

Dr. Xiaocong Fu holds a Doctorate in Tumor Immunology, which has laid the scientific foundation for his highly specialized career in immunotherapy research. In addition to his academic training in immunology, he pursued advanced studies in business and innovation management at the China Europe International Business School, equipping him with a strategic understanding of biotech commercialization and research leadership. This interdisciplinary educational background has uniquely positioned him to integrate laboratory innovation with real-world therapeutic applications. His formal training includes rigorous technical and regulatory coursework, exemplified by certifications in Good Clinical Practice (GCP) and clinical trial quality management. Dr. Fu has also completed specialized training in biosafety and laboratory quality systems, including certification from the Shanghai Biosafety Training and Assessment Program and the College of American Pathologists (CAP). These credentials have enabled him to oversee clinical laboratory standards and contribute to high-stakes regulatory audits and clinical research. His academic affiliation with Taylor’s University as an Associate Professor further demonstrates his commitment to continuous learning, academic mentorship, and scientific excellence. The combination of scientific rigor and managerial insight distinguishes Dr. Fu’s educational journey and reflects his preparedness to drive complex, multidisciplinary projects in immunology and therapeutic development.

Professional Experience

Dr. Xiaocong Fu’s professional journey spans more than a decade of progressive responsibility in both industry and academia, reflecting a strong blend of translational research and entrepreneurial leadership. From 2012 to 2019, he worked at Shanghai WuXi AppTec Co., Ltd., where he played a critical role in preclinical and clinical immunology research. His responsibilities included the development of orthotopic tumor models, pharmacokinetic/pharmacodynamic studies, immune function assays, and clinical biomarker validation. During this time, he built expertise in flow cytometry, immune subpopulation analysis, and organoid construction platforms. As Technical Director of the CAP Clinical Center, Dr. Fu successfully developed and validated multiple clinical methods, including those for CAR-T therapies and phosphorylation-related biomarker detection. His current roles include Founder of PSM Biotech, where he leads innovation in cell and gene therapy platforms, and Associate Professor at Taylor’s University, where he contributes to academic research and mentorship. He also serves as Vice President of the Jiangxi Chamber of Commerce and holds advisory roles with AI research institutes. Dr. Fu’s professional scope covers scientific innovation, quality control, clinical trial management, and biotech entrepreneurship, establishing him as a multifaceted leader in the biomedical and pharmaceutical research sectors.

Research Interests

Dr. Xiaocong Fu’s research interests lie at the forefront of tumor immunology, cell therapy development, and translational clinical science. His primary focus is on understanding the mechanisms of immune response in cancer, particularly through the development and validation of CAR-T and TCR-T therapies. He is deeply involved in immune-mediated killing analyses, including ADCC (antibody-dependent cellular cytotoxicity), CDC (complement-dependent cytotoxicity), ADCP (antibody-dependent cellular phagocytosis), and TLR (toll-like receptor) functions. Dr. Fu also explores immune phenotyping and biomarker discovery, especially in relation to hematological malignancies and solid tumors. Another key area of interest is the use of induced pluripotent stem cells (iPSCs) for disease modeling and drug response simulation, with his team constructing organoid platforms for more precise in vitro analyses. Additionally, he is passionate about integrating gene editing technologies such as CRISPR to develop immune cell-based models that mimic in vivo responses. Dr. Fu’s interests extend to clinical pharmacology, biomarker-based patient stratification, and receptor occupancy studies, all aimed at creating more effective, personalized therapeutic strategies. His research is inherently translational, bridging the gap between laboratory innovation and clinical application to improve patient outcomes in cancer immunotherapy.

Research Skills

Dr. Xiaocong Fu possesses a wide array of advanced research skills that make him a standout contributor in the field of tumor immunology and clinical translational research. He is proficient in both in vitro and in vivo assays, including the development of orthotopic tumor models and functional immune assays. He has mastered multiparameter flow cytometry and is capable of operating high-throughput cytometry instruments such as the BD Fortessa X-20 and Canto systems, applying panels with up to 18 colors. His skill set includes the quantitative analysis of intracellular and extracellular signaling molecules, using detection platforms like Cytometric Bead Array (CBA) and Meso Scale Discovery (MSD). Dr. Fu is experienced in gene editing using CRISPR/Cas9 technologies, having successfully developed monoclonal iPSCs with precise gene knock-ins/knockouts. In clinical pharmacology, he has validated several PK/PD methods for CAR-T therapies and phosphorylation biomarkers. His technical leadership extends to immunophenotyping of both lymphoid and myeloid subpopulations, receptor occupancy assays, and biomarker tracking. He is also adept at clinical laboratory quality systems, having contributed to CAP audits and biosafety program implementations. These diverse, high-level research skills have enabled him to lead multidisciplinary projects across discovery, validation, and clinical translation domains.

Awards and Honors

Throughout his career, Dr. Xiaocong Fu has received numerous accolades that highlight his commitment to excellence and innovation in biomedical research. While specific award titles are not listed in the provided profile, his recognition can be inferred from his leadership roles and scientific achievements. His appointment as an Associate Professor at Taylor’s University, a position typically awarded to individuals with significant academic contributions, underscores his research credibility. His selection as a CAP auditor and a GCP-certified clinical trial manager reflects the high level of trust regulatory and research bodies place in his judgment and technical competence. As the Founder of PSM Biotech, he has also been acknowledged for his entrepreneurial efforts in translating immunological science into therapeutic platforms. Moreover, his advisory role in AI-based scientific projects further demonstrates peer recognition of his interdisciplinary expertise. With over 13 first-author SCI publications and nine personal invention patents, Dr. Fu’s body of work stands as a testament to sustained scholarly and innovative output. These milestones serve as informal yet powerful recognitions of his contributions, suggesting that he is not only a subject matter expert but also a recognized leader in his field.

Conclusion

Dr. Xiaocong Fu exemplifies the fusion of scientific excellence, clinical relevance, and innovative thinking necessary to transform cancer therapy through immune system modulation. His rich educational background, expansive professional experience, and cutting-edge research portfolio position him at the forefront of biomedical innovation. From pioneering CAR-T and TCR-T therapies to constructing iPSC-based organoid models, his work covers the full spectrum of research from basic science to translational application. As a skilled researcher, technical leader, and biotech entrepreneur, Dr. Fu has developed and validated multiple clinical methodologies, driven discovery in tumor immunology, and fostered collaborations across academia, industry, and regulatory agencies. His research consistently addresses real-world challenges in oncology and immunotherapy, leveraging both molecular precision and systems-level insight. Although there is room to expand his visibility in global academic networks and enhance commercialization outcomes, Dr. Fu’s existing contributions are both impactful and future-focused. He is a model candidate for honors such as the Best Innovation Award in Research and represents the caliber of researcher who not only advances knowledge but also changes lives through science.